Money Control Place
  • Politics
  • Business
  • Stocks
  • Investing
  • Politics
  • Business
  • Stocks
  • Investing

Money Control Place

Business

CVS Health to pull decongestants with phenylephrine off shelves

by October 20, 2023
October 20, 2023
CVS Health to pull decongestants with phenylephrine off shelves

U.S. pharmacy chain CVS Health said on Thursday it is pulling some of the most common decongestants with phenylephrine as the only active ingredient from its shelves and will no longer sell them.

The move comes after a panel of advisers to U.S. health regulators raised doubts over the efficacy of the ingredient.

Last month, the panel refused to back the effectiveness of oral over-the-counter (OTC) medicines made with phenylephrine, adding that no more trials were required to prove otherwise.

CVS said “other oral cough and cold products will continue to be offered to meet consumer needs.”

Phenylephrine was substituted for pseudoephedrine in many non-prescription cold and allergy medicines after the latter was restricted amid reports of abuse.

Phenylephrine is a major component used in some of popular products like Benadryl, Sudafed, GSK’s Advil and Kenvue’s Tylenol.

This post appeared first on NBC NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Tesla Stock Has High Expectations: A Strong Pop or Plunge
next post
Mortgage demand falls to the lowest level since 1995 as interest rates near 8%

Related Posts

Alphabet beats earnings expectations, raises spending forecast

July 25, 2025

Oil prices rise more than 1% as Israel...

June 21, 2025

Wells Fargo customers scramble after deposits disappear from...

August 5, 2023

What the Ticketmaster-Live Nation lawsuit could mean for...

May 25, 2024

Sam Altman joins Microsoft to lead new AI...

November 20, 2023

Average credit card balances jump 10% to a...

February 9, 2024

U.S. online stores put ‘out of stock’ signs...

June 12, 2025

Credit card balances spiked in the third quarter...

November 8, 2023

As Joann Fabrics and JCPenney announce store closings,...

February 18, 2025

The lunch rush is dead as Americans live...

May 20, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    • BHP: Targeted AI Platforms Boost Efficiency, Safety and More

    • New Found Gold Announces US$75 Million Term Sheet to Advance Queensway Development

    • Copper Quest Completes AI-Driven Analysis at Kitimat & Identifies Large Concealed Conductive Target

    • Oreterra Announces Closing of Final Tranche of $9.7 Million Oversubscribed and Upsized Non-Brokered Private Placement

    • Precious Metals Price Update: Gold, Silver, PGMs Fall on Escalating US-Iran War

    Categories

    • Business (1,440)
    • Investing (3,583)
    • Politics (3,699)
    • Stocks (1,961)
    • Uncategorized (20)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: MoneyControlPlace.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 moneycontrolplace.com | All Rights Reserved